Inclusion Criteria:
* Intracerebral Hemorrhage Group (Stroke Patients)
Adults aged 19 to 80 years.
Diagnosed with intracerebral hemorrhage based on clinical evaluation and neuroimaging findings.
Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.
Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.
Cerebral Infarction Group (Stroke Patients)
Adults aged 19 to 80 years.
Diagnosed with cerebral infarction (ischemic stroke) based on clinical evaluation and neuroimaging findings.
Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.
Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.
Healthy Adult Group
Adults aged 19 to 80 years.
No history of stroke or transient ischemic attack (TIA).
No major stroke risk factors such as hypertension, diabetes mellitus, or hyperlipidemia.
No chronic diseases, including cardiovascular disease, chronic kidney disease, or chronic pulmonary disease.
No psychiatric disorders, such as depression or schizophrenia.
Not taking medications that may affect cerebral hemodynamics, including antihypertensive agents, anticoagulants, antiplatelet agents, or antidepressants.
Able to read and understand the participant information sheet and consent form, and capable of completing questionnaires in the study language.
Voluntarily agrees to participate in the study, provides written informed consent, and is able to participate for the entire study period.
Exclusion Criteria:
* Participants meeting any of the following exclusion criteria will not be enrolled in the study.
History of head trauma or cranial surgery within the past 6 months with wounds that have not yet fully healed.
Current diagnosis of a severe psychiatric disorder, such as schizophrenia, major depressive disorder, or bipolar disorder.
Participation in another clinical study and intake of an investigational drug within the past 30 days.
Women who are pregnant or breastfeeding.
Presence of an acute infection or inflammatory disease.
Inability to adequately understand the study procedures or lack of voluntary consent to participate.
Any other clinically significant finding that, in the judgment of the principal investigator or designated study physician, makes the individual unsuitable for participation in this study.
